ATYR Q2 2023 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$586,000

Operating Income

-$14M

Net Income

-$12M

EPS (Diluted)

$-0.22

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$14M

Stock-Based Comp.

$658,000

Balance Sheet

Total Assets

$133M

Total Liabilities

$27M

Stockholders' Equity

$106M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$586,000	$0	—
Operating Income	-$14M	-$13M	-7.7%
Net Income	-$12M	-$12M	+0.7%